InvestorsHub Logo
Followers 41
Posts 1956
Boards Moderated 0
Alias Born 03/24/2014

Re: None

Friday, 04/22/2022 9:54:40 AM

Friday, April 22, 2022 9:54:40 AM

Post# of 693128
This looks like an interesting line up on May 10th: https://events.nyas.org/event/28ca5e39-51a7-4e73-be3d-78089c92d596/websitePage:ccf12eed-4b47-487c-82af-faa589df6e0a

Session 5: Unique Challenges in Emerging Immunotherapies
9:00 AM-10:40 AM
9:00 AM
Welcome Remarks

Barbara Knappmeyer, PhD, The New York Academy of Sciences
Session 6: Unique Challenges in Emerging Immunotherapies
Session Chair: To be announced

9:10 AM
Immune Checkpoint Blockade in Glioblastoma
David Reardon, MD, Dana Farber Cancer Institute

9:40 AM
How Do CAR T Cells Kill Cancer?
Marcela V. Maus, MD, PhD, Massachusetts General Hospital, Harvard Medical School

10:10 AM
Immunotherapeutic approaches to Glioblastoma Treatment
Vinay K. Puduvalli, MD, MD Anderson Cancer Center
Networking Break

10:40 AM-11:10 AM
Session 6: Unique Challenges in Emerging Immunotherapies (Continued)
11:10 AM-12:10 PM

11:10 AM
Autologous Tumor Lysate-loaded Dendritic Cell Vaccination for Glioblastoma
Linda M. Liau, MD, PhD, University of California, Los Angeles

11:40 AM
Independent Drug Action in Immunotherapy: Implications for Drug Discovery and Precision Medicine
Peter Sorger, PhD, Harvard Medical School
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News